🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination

Recruitingn/aAges 18 Years - 60 YearsAllGuangdong Provincial People's Hospital
NCT07505862 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a cross-sectional study that primarily employs quantitative analysis, supplemented by qualitative assessment. The research is conducted in two stages: Phase I consists of a model performance comparison experiment, and Phase II involves an item quality evaluation experiment. The entire study adheres to the principles of single-blinding, randomization, and standardization to ensure scientific rigor and reproducibility. The single-blind design is implemented during the "standardized testing" phase, where the system intersperses AI-generated items with those authored by human experts. Participants remain blinded to the source of each item (AI-generated vs. human-authored) throughout the testing and scoring processes, thereby ensuring the objectivity of the evaluation results.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 1.Professional Status: Medical students currently enrolled in a Standardized Residency Training (SRT) program. 2.Educational Background: Holders of a Bachelor of Medicine degree or higher, with foundational clinical knowledge. 3.Informed Consent: Voluntarily participate in the study and provide written informed consent. 4.Technical Competency: Proficient in using digital platforms to complete assessments and scoring. Exclusion Criteria: * 1.Conflict of Interest: Individuals involved in the AI model training, prompt engineering, or the creation of the human-authored question bank for this study. 2.Inability to Complete: Presence of visual/auditory impairments or severe illness that precludes completion of the assessment within the specified time. 3.Investigator's Discretion: Any other condition that, in the opinion of the investigator, renders the participant unsuitable for the study.
💊

What it tests

  • Not listed
📍

Where

1 site
Guangdong Provincial People's Hospital
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy